[1]CurrentPatentAssignee:ASTELLASPHARMAINC.-WO2008/72784,2008,A1Locationinpatent:Page/Pagecolumn102-103
[1]Bhunia,SamirKumar;Das,Pritha;Nandi,Shantanu;Jana,Ranjan[OrganicLetters,2019,vol.21,#12,p.4632-4637]
1207194-48-6
220499-11-6
127956-28-9
272438-11-6
354587-72-7
279256-09-6
759456-60-5 | (5-amino-2-morpholinophenyl)methanol | AA00G7I1 | MFCD11841019
76279-32-8 | (S)-1-(2,6-Dimethoxyphenyl)ethanamine | AA00G7ZL | MFCD06762482
787640-16-8 | 2-Hydroxy-5-(trifluoromethyl)nicotinic acid | AA00G8G0 | MFCD10696243
83255-87-2 | 3-Bromo-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | AA00G97N | MFCD22375270
78626-99-0 | Benzyl N-[(1S)-1-(isopropylcarbamoyl)ethyl]carbamate | AA00G9JF | MFCD22586687
849619-11-0 | (E)-1-(4-Bromophenyl)-3-(dimethylamino)prop-2-en-1-one | AA00G9QI | MFCD00121187
848591-90-2 | A 582941 | AA00GA2K | MFCD20926358
851199-60-5 | Linaclotide acetate | AA00GAJT | MFCD21607788
781-89-5 | BETA-METHYL-BETA-NITRO-2'-(TRIFLUOROMETHYL)STYRENE | AA00GCTP | MFCD01317566
77572-72-6 | silabolin | AA00GGNK | MFCD01746260